HKEX Stock Code: 01093English|繁體|简体

2025H1 Results

  • Revenue RMB 13,273M, -18.5%
  • Reported profit attributable to shareholders of the Company RMB2,548M, -15.6%
  • Underlying profit attributable to shareholders of the Company RMB2,320M, -27.9%
  • Basic earnings per share (based on reported profit) RMB22.29 cents, -12.6%
  • Basic earnings per share (based on underlying profit) RMB20.29 cents, -25.3%

Highlight - 2025H1 Results

Revenue
RMB 13,273M, -18.5%
Reported profit attributable to shareholders of the Company
RMB2,548M, -15.6%
Underlying profit attributable to shareholders of the Company
RMB2,320M, -27.9%
Basic earnings per share (based on reported profit)
RMB22.29 cents, -12.6%
Basic earnings per share (based on underlying profit)
RMB20.29 cents, -25.3%

Corporate Governance

Corporate Governance

Financial Calendar

Aug
22
Aug
22
May
30
May
29
May
29
Mar
28
Mar
28

Financial Reports

Financial Reports

Financial Summary

Financial Summary

IR Contacts

Address : Suite 3206, 32/F, Central Plaza,
18 Harbour Road, Wanchai, Hong Kong
Tel : (852) 2500 3144
Fax : (852) 2802 4552
E-mail : ir@cspc.hk
© Copyright 2025 CSPC Pharmaceutical Group Limited. All Rights Reserved.